US Patent Issued to AbCellera Biologics on Sept. 15 for "CD3 t-cell engagers and methods of use" (Canadian Inventors)

ALEXANDRIA, Va., Sept. 15 -- United States Patent no. 12,735,494, issued on Sept. 15, was assigned to AbCellera Biologics Inc. (Canada).

"CD3 t-cell engagers and methods of use" was invented by Lindsay Devorkin (Vancouver, Canada), Aaron Paul Yamniuk (Vancouver, Canada), Bryan Crawford Barnhart (Vancouver, Canada), Wei Wei (Vancouver, Canada), Kevin Albert Heyries (Vancouver, Canada), Harveer Dhupar (Vancouver, Canada), Sherie Duncan (Vancouver, Canada) and Timothy M. Jacobs (Vancouver, Canada).

According to the abstract* released by the U.S. Patent & Trademark Office: "Anti-CD3 antibodies for use in the diagnosis or treatment of hyperproliferative or autoimmune disorders methods of using the same for detecting and/or treating a hyperprol...